| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥16.1B | ¥14.2B | +13.5% |
| Operating Income | ¥-0.3B | ¥0.6B | -157.9% |
| Ordinary Income | ¥-0.3B | ¥0.5B | -164.8% |
| Net Income | ¥-0.4B | ¥0.5B | -177.9% |
| ROE | -21.6% | 25.0% | - |
FY2025 Q3 cumulative results: Revenue 1,613M yen (YoY +13.5%), Operating Loss -33M yen (prior year Operating Income +58M yen, YoY -157.9%), Ordinary Loss -33M yen (prior year Ordinary Income +53M yen, YoY -164.8%), Net Loss -39M yen (prior year Net Income +50M yen, YoY -177.9%). The company achieved double-digit revenue growth but swung to operating loss as SG&A expenses of 592M yen exceeded gross profit of 559M yen. Gross profit margin maintained at 34.7%, but operating margin declined to negative 2.0%. Total assets decreased to 1,042M yen from prior year 1,743M yen, while equity declined to 182M yen from 204M yen, resulting in equity ratio deterioration to 17.5%. Cash and deposits fell 59.2% YoY to 179M yen, indicating significant liquidity pressure. The company maintains full-year guidance projecting continued losses with revenue of 1,750M yen (+5.3% YoY) and operating loss of 190M yen, reflecting structural profitability challenges despite top-line growth momentum.
Revenue increased 192M yen or 13.5% YoY to 1,613M yen, driven by growth across both geographic segments. Japan segment sales rose 16.8% to 1,214M yen while America segment sales increased 4.6% to 399M yen. The Japan segment accounts for 75.2% of consolidated revenue, establishing it as the core geographic market. Despite revenue expansion, profitability deteriorated sharply with operating income swinging from positive 58M yen to negative 33M yen, a decline of 91M yen. This represents a revenue up/profit down pattern. The primary driver of profit deterioration was Japan segment turning from operating profit of 38M yen to operating loss of 13M yen, a decline of 51M yen. America segment operating loss expanded from 41M yen to 52M yen, widening by 11M yen. According to segment reconciliation details, allowance for doubtful accounts adjustments contributed 22M yen to consolidated results compared to 50M yen in prior year, indicating deterioration in receivables quality. Inter-segment transaction eliminations and internal profit adjustments together contributed approximately 10M yen to consolidated operating results, relatively flat YoY. SG&A expenses grew faster than revenue, eroding the gross profit margin advantage. Ordinary loss of 33M yen closely matched operating loss, indicating minimal non-operating impact. Net loss of 39M yen exceeded ordinary loss by 6M yen, suggesting modest extraordinary or tax-related factors. The segment disclosure reveals no impairment losses or goodwill-related items for the period. The profitability decline stems primarily from operating execution challenges in Japan and persistent losses in America operations, rather than one-time extraordinary factors.
Japan segment generated revenue of 1,412M yen including inter-segment sales of 198M yen, with external sales of 1,214M yen representing 75.2% of consolidated revenue, establishing it as the core business. The segment recorded operating loss of 13M yen, deteriorating from operating profit of 38M yen in the prior year, a swing of 51M yen. America segment posted revenue of 399M yen (24.8% of consolidated total) with operating loss of 52M yen, worsening from prior year loss of 41M yen by 11M yen. Operating margin in Japan declined from positive 3.0% to negative 0.9%, while America margin worsened from negative 10.7% to negative 13.0%. The margin differential between segments widened significantly, with America underperforming Japan by approximately 12 percentage points. Both segments remain unprofitable on consolidated basis after headquarters cost allocations, with combined segment loss before adjustments totaling 65M yen compared to prior year segment loss of 3M yen.
[Profitability] Operating margin negative 2.0% (deteriorated from positive 4.1% YoY), net profit margin negative 2.4% (declined from positive 3.5% YoY), gross profit margin 34.7% maintained at relatively healthy level indicating pricing power preservation despite volume challenges. ROE negative 21.4% (worsened from positive 24.9% YoY), driven by net loss combined with high financial leverage of 5.73x amplifying negative earnings impact on diminished equity base. ROA negative 3.7% (deteriorated from positive 2.9% YoY). [Cash Quality] Cash and deposits 179M yen decreased 59.2% YoY, covering 1.56x of short-term borrowings at 115M yen but overall liquidity position weak. [Investment Efficiency] Total asset turnover 1.55x (improved from 0.82x YoY) due to asset base contraction alongside revenue growth, but efficiency gain offset by profitability collapse. Inventory turnover 98 days, with work-in-process comprising 91% of total inventory at 214M yen indicating extended production cycle. Receivables turnover 71 days (DSO) and cash conversion cycle 146 days both exceed manufacturing sector norms, highlighting working capital inefficiency. [Financial Health] Equity ratio 17.5% (declined from 11.7% YoY), current ratio 98.6% (below safety threshold of 1.0x), debt-to-equity ratio 4.73x, indicating elevated financial risk. Contract liabilities of 469M yen represent significant advance customer payments requiring fulfillment monitoring.
Cash and deposits decreased 260M yen YoY to 179M yen, representing 59.2% decline and indicating significant cash outflow during the period. The sharp cash reduction occurred despite 13.5% revenue growth, suggesting operating loss of 33M yen combined with working capital deterioration absorbed substantial cash. Trade receivables increased to 314M yen with DSO extending to 71 days, implying approximately 45M yen incremental working capital tied up in receivables compared to normalized collection patterns. Work-in-process inventory expanded to 214M yen comprising 91% of total inventory, reflecting extended production cycles that delay cash realization. Trade payables decreased 28.0% to 18M yen, indicating accelerated supplier payments that consumed cash. Contract liabilities of 469M yen represent advance customer receipts providing partial working capital financing, though execution timing affects ultimate cash conversion. Current assets declined to 523M yen while current liabilities remained at 530M yen, yielding current ratio of 98.6% barely below parity and highlighting constrained short-term liquidity. The combination of operating losses, receivables buildup, inventory extension, and payables reduction created cash drain reflected in the 260M yen deposit decline. With cash covering 1.56x short-term debt but overall liquidity tight, refinancing execution and working capital management are critical near-term priorities.
Operating loss of 33M yen approximated ordinary loss of 33M yen, indicating negligible net non-operating income contribution for the period. Non-operating items added minimal impact to operating results, with the 0.1M yen difference representing less than 0.01% of revenue and suggesting primary earnings drivers remained operational. Net loss of 39M yen exceeded ordinary loss by 6M yen, implying modest extraordinary items or tax effects contributing approximately 0.4% of revenue impact. The segment reconciliation reveals allowance for doubtful accounts adjustment of 22M yen boosted consolidated operating results, down from 50M yen benefit in prior year, indicating declining credit quality trends. The absence of cash flow statement data limits accruals assessment, but cash and deposits declining 59.2% while reporting net loss of 39M yen suggests cash outflows significantly exceeded accounting losses. The divergence between cash reduction of 260M yen and net loss of 39M yen implies approximately 220M yen additional cash consumption from working capital, investments, or financing activities. With DSO at 71 days and cash conversion cycle at 146 days both elevated, receivables and inventory represent significant accrued assets not yet converted to cash. The high work-in-process ratio of 91% indicates revenue recognition potentially occurring before cash collection, warranting attention to revenue realization quality. Overall earnings quality appears compromised by weak cash generation relative to reported losses and elevated working capital intensity.
Full-year guidance projects revenue of 1,750M yen (+5.3% YoY), operating loss of 190M yen, ordinary loss of 200M yen, and net loss of 230M yen. Q3 cumulative progress rates stand at revenue 92.2%, operating loss 17.4%, ordinary loss 16.5%, and net loss 16.9% of full-year projections. Revenue progress of 92.2% significantly exceeds standard 75% Q3 benchmark, indicating Q4 revenue guidance of only 137M yen or 7.8% of full-year target, representing substantial deceleration from Q3 quarterly run-rate of approximately 538M yen. Operating loss progress of 17.4% implies Q4 operating loss of 157M yen, substantially larger than Q3 cumulative loss of 33M yen and suggesting expected sharp deterioration in Q4 profitability. The guidance assumes revenue moderation while expense pressures intensify in the final quarter. Net loss guidance of 230M yen for full-year implies 191M yen net loss expected in Q4 alone, nearly five times the Q3 cumulative loss and indicating anticipated extraordinary charges, tax impacts, or severe operating deterioration. The significant acceleration of projected losses in Q4 relative to Q3 cumulative results suggests either seasonality factors, one-time charges, or conservative provisioning not yet reflected. Dividend guidance remains zero yen, consistent with loss projections and capital preservation priorities.
Liquidity and Refinancing Risk: Current ratio of 98.6% below safety threshold combined with cash decline of 59.2% to 179M yen and short-term liabilities ratio of 61.2% creates immediate refinancing pressure, particularly as Q4 guidance implies accelerated loss consumption requiring secured funding access or covenant management.
Geographic Concentration and America Segment Drag: America segment operating margin of negative 13.0% deteriorating from negative 10.7% represents persistent overseas profitability challenge, with 52M yen operating loss from 399M yen sales indicating structural issues requiring operational turnaround or strategic review to prevent continued consolidated earnings drag.
Working Capital Intensity and Cash Conversion: Work-in-process representing 91% of inventory at 214M yen combined with DSO of 71 days and cash conversion cycle of 146 days demonstrates extended production and collection processes consuming capital, with approximately 220M yen working capital cash outflow beyond reported losses in current period requiring process reengineering and collection acceleration to restore cash generation.
[Industry Position] (Reference - Proprietary Analysis)
Profitability: Operating margin negative 2.0% significantly underperforms manufacturing industry median of positive 8.3% by 10.3 percentage points, placing the company below the 25th percentile and indicating severe competitive disadvantage. Net profit margin negative 2.4% versus industry median positive 6.3% reflects 8.7 percentage point gap. ROE negative 21.4% compares unfavorably to industry median positive 5.0%, though high financial leverage of 5.73x versus industry median 1.53x amplifies earnings volatility. ROA negative 3.7% trails industry median positive 3.3% by 7.0 percentage points.
Efficiency: Asset turnover of 1.55x substantially exceeds industry median of 0.58x, ranking in top quartile and demonstrating superior asset utilization efficiency. However, elevated DSO of 71 days versus industry median 82.87 days appears relatively favorable, though company's cash conversion cycle of 146 days significantly exceeds industry median operating working capital turnover of 108 days, indicating extended cash conversion despite faster nominal receivables collection. Inventory turnover of 98 days compares favorably to industry median 108.81 days.
Financial Health: Equity ratio of 17.5% substantially below industry median 63.8% places company in bottom quartile, indicating elevated financial risk. Current ratio 98.6% severely trails industry median 2.84x, highlighting acute liquidity stress versus sector norms. Debt-to-equity ratio of 4.73x far exceeds typical manufacturing leverage, though direct industry comparison unavailable from median data.
Growth: Revenue growth of 13.5% YoY outperforms industry median 2.7% significantly, placing company in top quartile for top-line expansion despite profitability challenges.
The company demonstrates strong revenue growth momentum and asset efficiency but faces severe profitability and financial health disadvantages relative to manufacturing sector peers, with leverage and liquidity metrics warranting immediate attention. (Industry: Manufacturing, N=98 companies, Period: 2025-Q3, Source: Proprietary Analysis)
Revenue Growth Momentum Disconnected from Profitability: The company achieved 13.5% YoY revenue growth outpacing manufacturing industry median of 2.7% and ranking in top quartile for sales expansion, yet operating margin declined to negative 2.0% versus industry median positive 8.3%, creating a 10.3 percentage point profitability gap. This divergence between volume success and margin failure indicates pricing discipline erosion, cost structure misalignment, or product mix deterioration requiring management corrective action. The Q3 cumulative results show revenue approaching full-year guidance at 92.2% progress rate while operating losses represent only 17.4% of projected full-year losses, implying severe Q4 deterioration anticipated that could signal seasonal headwinds, one-time charges, or conservative provisioning not yet disclosed. Monitoring Q4 execution against guidance and management commentary on margin recovery initiatives will determine whether current losses represent cyclical trough or structural impairment.
Critical Liquidity Position Requiring Near-Term Attention: Current ratio of 98.6% places the company significantly below manufacturing industry median of 2.84x and approaches distress threshold, while cash deposits declined 59.2% to 179M yen covering only 1.56x short-term borrowings. With equity ratio of 17.5% versus industry median 63.8% and debt-to-equity ratio of 4.73x indicating high leverage, refinancing risk and covenant compliance emerge as immediate concerns. The cash burn of 260M yen during Q3 cumulative period despite 13.5% revenue growth highlights working capital management challenges, with DSO of 71 days and particularly work-in-process inventory at 91% of total inventory (214M yen) indicating extended cash conversion cycles consuming liquidity. Contract liabilities of 469M yen provide partial offset through customer advances, but execution delivery timeline governs ultimate cash release. Investors should prioritize monitoring cash flow statements when available, credit facility renewals, working capital turnover improvements, and any asset monetization or capital raise announcements as indicators of liquidity stabilization.
Geographic Profitability Imbalance and Operational Execution Gap: Japan segment comprising 75.2% of revenue swung from operating profit to loss, while America segment operating margin deteriorated from negative 10.7% to negative 13.0%, with combined segment losses before adjustments reaching 65M yen versus 3M yen prior year. The America segment persistent double-digit operating margin deficit despite 4.6% revenue growth suggests structural challenges requiring strategic review, potential restructuring, or exit consideration. Manufacturing sector positioning shows strong asset turnover of 1.55x versus industry median 0.58x indicating operational efficiency capability, yet this efficiency fails to translate to profitability due to cost structure burden, particularly visible in SG&A expenses of 592M yen exceeding gross profit of 559M yen. Management's ability to rationalize cost base, improve America segment performance, accelerate work-in-process turnover, and demonstrate path to breakeven represents key determinant of investment viability beyond near-term liquidity stabilization.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.